211 related articles for article (PubMed ID: 22039516)
21. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
[TBL] [Abstract][Full Text] [Related]
22. Phenethyl isothiocyanate inhibits androgen receptor-regulated transcriptional activity in prostate cancer cells through suppressing PCAF.
Yu C; Gong AY; Chen D; Solelo Leon D; Young CY; Chen XM
Mol Nutr Food Res; 2013 Oct; 57(10):1825-33. PubMed ID: 23661605
[TBL] [Abstract][Full Text] [Related]
23. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
Hu J; Straub J; Xiao D; Singh SV; Yang HS; Sonenberg N; Vatsyayan J
Cancer Res; 2007 Apr; 67(8):3569-73. PubMed ID: 17440067
[TBL] [Abstract][Full Text] [Related]
24. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
Xu C; Shen G; Chen C; Gélinas C; Kong AN
Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023
[TBL] [Abstract][Full Text] [Related]
25. DNA methylome, transcriptome, and prostate cancer prevention by phenethyl isothiocyanate in TRAMP mice.
Wu R; Li S; Sargsyan D; Yin R; Kuo HC; Peter R; Wang L; Hudlikar R; Liu X; Kong AN
Mol Carcinog; 2021 Jun; 60(6):391-402. PubMed ID: 33848375
[TBL] [Abstract][Full Text] [Related]
26. Differential response of normal (PrEC) and cancerous human prostate cells (PC-3) to phenethyl isothiocyanate-mediated changes in expression of antioxidant defense genes.
Powolny AA; Singh SV
Pharm Res; 2010 Dec; 27(12):2766-75. PubMed ID: 20872049
[TBL] [Abstract][Full Text] [Related]
27. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo.
Xiao D; Singh SV
Cancer Res; 2007 Mar; 67(5):2239-46. PubMed ID: 17332354
[TBL] [Abstract][Full Text] [Related]
28. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition.
Aggarwal M; Saxena R; Asif N; Sinclair E; Tan J; Cruz I; Berry D; Kallakury B; Pham Q; Wang TTY; Chung FL
J Exp Clin Cancer Res; 2019 Jul; 38(1):307. PubMed ID: 31307507
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells.
Wang H; Wang L; Cao L; Zhang Q; Song Q; Meng Z; Wu X; Xu K
Mol Carcinog; 2018 Apr; 57(4):522-535. PubMed ID: 29278657
[TBL] [Abstract][Full Text] [Related]
30. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
[TBL] [Abstract][Full Text] [Related]
31. Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest.
Chiao JW; Wu H; Ramaswamy G; Conaway CC; Chung FL; Wang L; Liu D
Carcinogenesis; 2004 Aug; 25(8):1403-8. PubMed ID: 15016658
[TBL] [Abstract][Full Text] [Related]
32. Bim contributes to phenethyl isothiocyanate-induced apoptosis in breast cancer cells.
Hahm ER; Singh SV
Mol Carcinog; 2012 Jun; 51(6):465-74. PubMed ID: 21739479
[TBL] [Abstract][Full Text] [Related]
33. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.
Lee J; Sehrawat A; Singh SV
Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833
[TBL] [Abstract][Full Text] [Related]
34. Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells.
Mohamed AA; Tan SH; Xavier CP; Katta S; Huang W; Ravindranath L; Jamal M; Li H; Srivastava M; Srivatsan ES; Sreenath TL; McLeod DG; Srinivasan A; Petrovics G; Dobi A; Srivastava S
Mol Cancer Res; 2017 Oct; 15(10):1308-1317. PubMed ID: 28607007
[TBL] [Abstract][Full Text] [Related]
35. Notch signaling dynamics in the adult healthy prostate and in prostatic tumor development.
Pedrosa AR; Graça JL; Carvalho S; Peleteiro MC; Duarte A; Trindade A
Prostate; 2016 Jan; 76(1):80-96. PubMed ID: 26419726
[TBL] [Abstract][Full Text] [Related]
36. Modulation of growth of human prostate cancer cells by the N-acetylcysteine conjugate of phenethyl isothiocyanate.
Chiao JW; Chung F; Krzeminski J; Amin S; Arshad R; Ahmed T; Conaway CC
Int J Oncol; 2000 Jun; 16(6):1215-9. PubMed ID: 10811998
[TBL] [Abstract][Full Text] [Related]
37. Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.
Xiao D; Singh SV
Pharm Res; 2010 Apr; 27(4):722-31. PubMed ID: 20182772
[TBL] [Abstract][Full Text] [Related]
38. Fatty Acid Synthesis Intermediates Represent Novel Noninvasive Biomarkers of Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate.
Singh KB; Singh SV
Cancer Prev Res (Phila); 2017 May; 10(5):279-289. PubMed ID: 28292742
[TBL] [Abstract][Full Text] [Related]
39. Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells.
Gong A; He M; Krishna Vanaja D; Yin P; Karnes RJ; Young CY
Mol Nutr Food Res; 2009 Jul; 53(7):878-86. PubMed ID: 19437484
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment.
Hudson TS; Perkins SN; Hursting SD; Young HA; Kim YS; Wang TC; Wang TT
Int J Oncol; 2012 Apr; 40(4):1113-21. PubMed ID: 22266918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]